(2026). Efficacy and safety of pyrotinib-based regimens in patients with HER2-positive stage III/IV breast cancer: A real-world retrospective study in China. PeerJ.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Efficacy and Safety of Pyrotinib-based Regimens in Patients with HER2-positive Stage III/IV Breast Cancer: A Real-world Retrospective Study in China."
PeerJ 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Efficacy and Safety of Pyrotinib-based Regimens in Patients with HER2-positive Stage III/IV Breast Cancer: A Real-world Retrospective Study in China."
PeerJ, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.